NNRTIs in Development: Overview

Early Pre-Clinical Development of GW8248 Promising (September 14, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
New Anti-HIV Therapies: Capravirine (January 2003)
From Project Inform
New Anti-HIV Therapies: Other New NNRTIs (January 2003)
From Project Inform
New Anti-HIV Therapies: New NNRTIs (January 2003)
From Project Inform
Non-Nucleoside Reverse Transcriptase Inhibitors (Summer/Autumn 2002)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Experimental NNRTI Drugs (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Pharmacokinetics of MKC-422, One of the Next Non-Nucleoside Reverse Transcriptase Inhibitors, Together With ZDV, 3TC, d4T, and ddI (June 29, 1998)
In The 12th International AIDS Conference, from TheBodyPRO.com

< Previous | 1 | 2

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's New! TheBody.com App
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.